China Shineway Pharmaceutical Group Limited
2877
Classificação em ações
#10984
As an investment holding enterprise, China Shineway Pharmaceutical Group... As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.
Preço da ação
$0.95560894
Valor de mercado
$721.87M
Variação (1 dia)
0.40%
Variação (1 ano)
-95.04%
País
CN
Negociar China Shineway Pharmaceutical Group Limited (2877)
Categoria
Healthcare
Histórico de rendimento de dividendos para China Shineway Pharmaceutical Group Limited (2877)
O rendimento de dividendos (TTM) da China Shineway Pharmaceutical Group Limited (símbolo da ação: 2877) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para China Shineway Pharmaceutical Group Limited (2877) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
| Ano | Rendimento de Dividendos | Alterar |
|---|---|---|
| Não há dados suficientes para as datas fornecidas. | ||
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
| Empresa | Rendimento de Dividendos | País |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|